Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05940402
What this trial is testing

Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function

Who this might be right for
Renal Impairment
AbbVie 58
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Early research (Phase 1)Ended earlyNCT04552262
What this trial is testing

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

Who this might be right for
Moderate Chronic Kidney Disease
Bayer 7
Post-approval studies (Phase 4)Study completedNCT00786136
What this trial is testing

Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes

Who this might be right for
Diabetes MellitusChronic Kidney Disease
Shenyang Northern Hospital 2,998
Early research (Phase 1)Study completedNCT01120314
What this trial is testing

Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal Impairment

Who this might be right for
Renal Impairment
Sanofi 48
Early research (Phase 1)Study completedNCT07154901
What this trial is testing

Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)

Who this might be right for
Renal Impairment
AstraZeneca 35
Large-scale testing (Phase 3)Study completedNCT00765830
What this trial is testing

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)

Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Novartis 349
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Study completedNCT00614939
What this trial is testing

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes
AstraZeneca 572
Early research (Phase 1)WithdrawnNCT05406219
What this trial is testing

Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

Who this might be right for
Diabetic Neuropathic PainRenal ImpairmentHealthy Volunteers
Bayer
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Large-scale testing (Phase 3)Looking for participantsNCT06998862
What this trial is testing

Colchicine in Chronic Kidney Disease Patients

Who this might be right for
Chronic Kidney DiseaseCardiovascular Events
Hospital General Universitario Gregorio Marañon 744
Testing effectiveness (Phase 2)Study completedNCT02933827
What this trial is testing

Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease

Who this might be right for
Moderate to Severe Chronic Kidney Disease
UnicoCell Biomed CO. LTD 39
Early research (Phase 1)Study completedNCT00418366
What this trial is testing

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Who this might be right for
Renal InsufficiencyHemodialysis
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT02096718
What this trial is testing

Afatinib in Subjects With Kidney Dysfunction

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 30
Early research (Phase 1)WithdrawnNCT01407900
What this trial is testing

Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal Dysfunction

Who this might be right for
Heart FailureRenal Insufficiency
John A. Schirger
Testing effectiveness (Phase 2)Study completedNCT03610516
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 57
Not applicableStudy completedNCT07370662
What this trial is testing

Effect of Resistance Exercises and Relaxation Therapy on Physical Function and Quality Of Life in Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)
Rashid Latif Medical College 50
Early research (Phase 1)Study completedNCT06747520
What this trial is testing

Phase 1 Renal Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Who this might be right for
Renal Insufficiency
Ahon Pharmaceutical Co., Ltd. 24
Next Page